SPAG5 and cancer: New evidence on the function of SPAG5 in numerous signalling pathways has shown that it is linked to cancer development, progression, and unfavourable clinical conditions, with elevated SPAG5 expression correlated with adverse clinicopathological features and poor clinical outcomes in multiple cancer types (Wang et al. 2021; Yang et al. 2018; Zeng et al. 2022).